ARCHIVES

OMB Cut $150 Million From NCI Request

This article is from The Cancer Letter archive.

Vol. 01 No. 07 | March 22, 1974

Download PDF Visit The Full Archive

Related Articles

Wiernik Loses Post At Einstein Following Unauthorized Trials

November 5, 1993

ASCO Recommends Aromatase Inhibitors As Adjuvant For Some Breast Cancer

July 30, 2010

Peer Review Study Team Plans Hearing

December 12, 1975

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

July 27, 2007

GAO Criticizes Distribution Of Comprehensive Cancer Centers, Cite Needs for “Focal Point” Clarification

March 26, 1976

In Brief: AACR, ASCO Meeting In Toronto; Regional Planners Threaten Cancer Program Delays

April 9, 1976